Short‐term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin‐releasing hormone in adult dialysis patients
Author:
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/article-pdf/15/6/856/23367671/150856.pdf
Reference22 articles.
1. Lamberts SW, Valk NK, Binnerts A. The use of growth hormone in adults: a changing scene. Clin Endocrinol1992; 37: 111–115
2. Hokken‐Koelega ASC, Stijnen T, de Muinck Keizer‐Schrama SMPF et al. Placebo‐controlled, double‐blind, cross‐over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet1991; 338: 585–590
3. Ziegler TR, Lazarus JM, Young LS, Hakim R, Wilmore DW. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol1991; 2: 1130–1135
4. Ikizler AT, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM. Short‐term effects of recombinant human growth hormone in CAPD patients. Kidney Int1994; 46: 1178–1183
5. Iglesias P, Díez JJ, Fernández‐Reyes MJ et al. Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study. Am J Kidney Dis1998; 32: 454–463
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3